Financial Highlights
| CONTINUING OPERATIONS | CHANGE | 2008/09 | 2007/08(5) |
|---|---|---|---|
| Revenue | +19% | £221.7m | £186.2m |
| Adjusted profit before taxation(1) | +17% | £39.0m | £33.4m |
| Statutory profit before taxation | +13% | £35.6m | £31.4m |
| Adjusted earnings per share(2) | +20% | 7.52p | 6.28p |
| Statutory earnings per share | +15% | 6.85p | 5.94p |
| Interim dividend per share | +5% | 3.15p | 3.00p |
| Return on sales(3) | 17.6% | 17.9% | |
| Return on total invested capital(4) | 14.7% | 13.9% | |
| Return on capital employed(4) | 57.1% | 58.5% |
Pro-forma information:
- Adjusted to remove the amortisation of acquired intangible assets of £3,399,000 (2007/08: £1,968,000).
- Adjusted to remove the amortisation of acquired intangible assets. See note 4 for details.
- Return on sales is defined as adjusted(1) profit before taxation from continuing operations expressed as a percentage of revenue from continuing operations.
- Organic growth rates, Return on capital employed (ROCE) and Return on total invested capital (ROTIC) are non-GAAP performance measures used by management in measuring the returns achieved from the Group's asset base. See note 9 for details.
- The comparative figures for 2007/08 as previously reported have been amended to account for the disposal of Post Glover Lifelink, Inc as a discontinued operation. See note 8 for details.
Halma operates in global
markets offering
long-term growth
underpinned by robust
growth
drivers. Our products help to provide
innovative solutions for many of the
key
issues facing the world today:
Demand for energy and water resources
Growth in population, ageing and urbanisation
Increasing demand for healthcare
Rising expectations of health and safety
